Academia.eduAcademia.edu

Figure 7. Affibody-sensor for the detection of human epidermal growth factor receptor 2 (HER2) biomarker. (a) Preparation of AuNP-graphite strip through electrodeposition. (b) Anti-HER2 immobilization over the AuNP-graphite strip. (c) Formation of MCH self-assembled monolayer with the anti- HER2 AuNP-graphite strip. (d) Addition of blocking agent to the electrode strip. (e) Interaction with HER2 and (f) the corresponding impedance signal [100]. Reprinted with permission from [100], Copyright © 2020 Published by Elsevier B.V. GSPEs: Graphite screen-printed electrodes, EIS: Electrochemical impedance spectroscopy.   that was linearly proportional to the logarithm OF the MepG- cell concentration. [70].  Affibody-based sensors are a result of using antibody mimicking bioengineered small protein (6 to 7 kDa) molecules to overcome the limitations of immunosensors [97]. These affibodies are engineered according to the need and have high binding affinity, selectivity, and survivability in high  temperature conditions [98]. Antibodies typically contain disulfide bonds that lead to poor heat 1 portion of the multidomain protein structure of antibodies is used in antigen detection [1,98]. This is where affibody technology comes into use. The parts of antibodies that are responsible for their affinity and selectivity towards antigens are engineered in vitro h various metal nanoparticles to further enhance their efficacy [99]  stability [1]. However, only a sma  These affibodies are often paired wit  An impedimetric strip ECB for human epidermal growth factor receptor 2  utilized affibody as the biorecogni  immobilizing the anti- HER2 affibodies. This resulted in selective interaction wi  tion element is shown in Figure 7 [100].  HER2) biomarker that AuNPs were used for th the HER2. Because of  that, the impedimetric charge transfer resistance increased linearly with increasing HER2 concentration  Analysis of the experimental results provided an LOD of 6 ug/L for the proposed sensor. Compared to  conventional immunosensors, the affibody sensor was more sensitive, provided a more rapid response,  and higher specificity [100].

Figure 7 Affibody-sensor for the detection of human epidermal growth factor receptor 2 (HER2) biomarker. (a) Preparation of AuNP-graphite strip through electrodeposition. (b) Anti-HER2 immobilization over the AuNP-graphite strip. (c) Formation of MCH self-assembled monolayer with the anti- HER2 AuNP-graphite strip. (d) Addition of blocking agent to the electrode strip. (e) Interaction with HER2 and (f) the corresponding impedance signal [100]. Reprinted with permission from [100], Copyright © 2020 Published by Elsevier B.V. GSPEs: Graphite screen-printed electrodes, EIS: Electrochemical impedance spectroscopy. that was linearly proportional to the logarithm OF the MepG- cell concentration. [70]. Affibody-based sensors are a result of using antibody mimicking bioengineered small protein (6 to 7 kDa) molecules to overcome the limitations of immunosensors [97]. These affibodies are engineered according to the need and have high binding affinity, selectivity, and survivability in high temperature conditions [98]. Antibodies typically contain disulfide bonds that lead to poor heat 1 portion of the multidomain protein structure of antibodies is used in antigen detection [1,98]. This is where affibody technology comes into use. The parts of antibodies that are responsible for their affinity and selectivity towards antigens are engineered in vitro h various metal nanoparticles to further enhance their efficacy [99] stability [1]. However, only a sma These affibodies are often paired wit An impedimetric strip ECB for human epidermal growth factor receptor 2 utilized affibody as the biorecogni immobilizing the anti- HER2 affibodies. This resulted in selective interaction wi tion element is shown in Figure 7 [100]. HER2) biomarker that AuNPs were used for th the HER2. Because of that, the impedimetric charge transfer resistance increased linearly with increasing HER2 concentration Analysis of the experimental results provided an LOD of 6 ug/L for the proposed sensor. Compared to conventional immunosensors, the affibody sensor was more sensitive, provided a more rapid response, and higher specificity [100].